ReviewJournal of Parkinson's disease

Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective.

Diane Stephenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.